PMID: 2119878Oct 15, 1990Paper

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

Cancer
R G van der HoopJ P Neijt

Abstract

In two consecutive trials, a total of 395 patients with ovarian cancer were treated with a combination of hexamethylmelamine, cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapeutic regimens including cisplatin or without this drug. With respect to neurotoxicity, 387 patients were fully eligible. The median follow-up for survival was 45 months. Neurotoxicity in any grade of severity developed in 47% of the patients treated with a cisplatin-containing regimen and in 25% of those treated with the non-cisplatin-containing regimen. The severity of neurotoxicity was much higher, however, in the cisplatin-treated patients. Neurotoxicity-free survival decreased below 50% at cumulative doses of cisplatin between 500 and 600 mg/m2. No additional effect of hexamethylmelamine on the incidence or severity of neurotoxicity could be demonstrated. In patients who survived for more than 5 years, the incidence of cisplatin neuropathy was 61%. Prognostic variables (age, International Federation of Gynecology and Obstetrics [FIGO] stage, performance status, and others) possibly associated with high-risk subgroups could not be identified. The only consistent factor correlated with neurotoxicity was the total dose of cisplatin received.

References

Mar 1, 1979·Cancer Treatment Reviews·A W PrestaykoS T Crooke
Jan 11, 1990·The New England Journal of Medicine·R G van der HoopW H Gispen
Apr 1, 1988·European Journal of Cancer & Clinical Oncology·R Gerritsen van der HoopW H Gispen
Sep 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R F OzolsR C Young
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S S Legha, I W Dimery
Sep 1, 1987·Experimental Neurology·P de KoningW H Gispen
Aug 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P NeijtJ B Vermorken
Mar 1, 1988·Neurology·J E MollmanL F McCluskey
Feb 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D D Von Hoff
Jun 1, 1987·European Journal of Cancer & Clinical Oncology·M J PiccartF Muggia
Feb 21, 1985·The New England Journal of Medicine·G S RichardsonJ H Nelson
May 3, 1985·Deutsche medizinische Wochenschrift·C MeierM Beer
Dec 1, 1983·Gynecologic Oncology·M AshrafE B Flink
Jul 1, 1984·Neurology·R I RoelofsL Rosenberg
Jun 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J P NeijtH M Pinedo
Jan 1, 1981·Cancer·A B MillerA Winkler

❮ Previous
Next ❯

Citations

Apr 15, 1996·Journal of Neuroscience Research·F P HamersW H Gispen
Mar 26, 2011·EMBO Molecular Medicine·Juliette DescoeurEmmanuel Bourinet
May 26, 2009·Cancer Chemotherapy and Pharmacology·Johnson J LiuMark J McKeage
Jul 10, 2009·Current Pain and Headache Reports·Deborah T Blumenthal
Nov 30, 2000·Current Treatment Options in Neurology·J H Uhm, W K Yung
May 1, 1995·Clinical Neurology and Neurosurgery·P H HilkensC J Vecht
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P H HilkensM J van den Bent
Sep 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·W H GispenJ P Neyt
Jan 8, 2000·Journal of Inorganic Biochemistry·D Screnci, M J McKeage
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J van den BentM E L van der Burg
Jan 22, 2004·Critical Reviews in Oncology/hematology·Sandro Pignata, Jan B Vermorken
Feb 9, 2012·Chemotherapy Research and Practice·Sousana Amptoulach, Nicolas Tsavaris
Aug 10, 2000·Drugs & Aging·R E van Rijswijk, J B Vermorken
Jan 7, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y OtowaY Kakeji
Jul 17, 2008·Supportive Cancer Therapy·G Kesava ReddyJeffrey Crawford
May 22, 2010·Neurología : publicación oficial de la Sociedad Española de Neurología·R Velasco, J Bruna
Sep 13, 2011·Critical Reviews in Oncology/hematology·Andreas A ArgyriouGuido Cavaletti
Oct 19, 2011·Journal of the Peripheral Nervous System : JPNS·Jordi BrunaEsther Udina
May 7, 2014·Basic & Clinical Pharmacology & Toxicology·Ahmed H Zedan, Ole J Vilholm
May 3, 2014·Basic & Clinical Pharmacology & Toxicology·Ole Jakob VilholmMustapha Itani
Sep 1, 1992·Toxicology and Applied Pharmacology·K BoekelheideJ Eveleth
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M PumarJ Vidal
Apr 1, 1994·Cancer Treatment Reviews·M K Tuxen, S W Hansen
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F P HarmersJ P Neijt
Apr 15, 2003·Neurologic Clinics·Scott R Plotkin, Patrick Y Wen
Dec 3, 2014·Blood Reviews·Rajiv S Magge, Lisa M DeAngelis
Jan 15, 2015·Der Nervenarzt·W BoehmerleM Endres
Mar 31, 2000·Journal of Neuroscience Research·M P ter LaakW H Gispen
Mar 25, 2009·Acta Oncologica·Elke E M BrouwersJan H M Schellens
Jul 22, 2017·Scientific Reports·Satoshi ImaiKazuo Matsubara
Dec 15, 1994·Annals of the New York Academy of Sciences·W H Gispen, F P Hamers
Sep 1, 1994·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P H HilkensM J van den Bent
Jun 18, 2017·Frontiers in Molecular Neuroscience·Hana Starobova, Irina Vetter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.